: Eligibility of Human Chorionic Gonadotrophin Inj. as Life Saving Drugs/Medicines Under S.No. 50A of Notification No. 20/99-Cus. dated 28.2.99 - exemption from Customs duty - Circular No.48/1999-Customs, dated 30.7.99
Circular - The Customs Act, 1962
- Kind: Circular
- Under: The Customs Act, 1962
Text of this circular
F.No.528/72/99-Cus (TU)
Circular No. 48/99-Cus
(TU) dated 30/7/1999
Government of India
Ministry of Finance
Department of Revenue
Central Board of Excise & Customs, New Delhi
Subject : Eligibility of Human Chorionic Gonadotrophin Inj. as Life Saving Drugs/Medicines Under S.No.
50A of Notification No. 20/99-Cus. dated 28.2.99 - exemption from Customs duty - reg.
I am directed to invite your attention on the above subject and to state that a doubt has been raised as to
whether "Human Chorionic Gonadotrophin" would be eligible for exemption from Customs duty as applicable to
Life Saving Drugs/Medicines under Notification No. 20/99-Cus. dated 28.2.99 or at the rate of 15% as applicable
to veterinary drugs and other goods under the said Notification. The doubt has particularly arisen because, in the
List (List II) attached to the said Notification, at S.No. 52, the item mentioned is Chorionic Gonadotrophin,
whereas in the List (List I) of veterinary drugs and other goods, at S.No. 14, the item mentioned is Human
Chorionic Gonadotrophin Hormone.
2. The matter has been examined by the Board. In Indian Pharmacopoeia, Human Chorionic Gonadotrophin
has been described as a dry, sterile preparation of placental glycoprotein and it is administrated to patients by
intra-muscular injection. Chorionic Gonadotrophin is extracted from the urine of pregnant women and the
material is sterilised by filtration and dried under reduced pressure or freeze-dried. As far as the usage of the
product is concerned, available pamphlets/literature suggests that the drug is used by women during the course
of their pregnancy.
3. It may be noted that in the Pharmacopoeia referred to above, Human Chorionic Gonadotrophin has been
mentioned under the heading Chorionic Gonadotrophin. Human Chorionic Gonadotrophin is thus included under
the category of Chorionic Gonadotrophin. Insofar as the issue of exemption is concerned, full exemption is
available to Chorionic Gonadotrophin figuring in List II annexed to Notification No. 20/99-Cus. dated 28.2.99 and
therefore, there appears to be no reason as to why the same concessional duty should be denied to Human
Chorionic Gonadotrophin Hormone merely on the ground that the latter figures in the list of veterinary drugs and
other goods in List 1 annexed to the said notification. It is a well settled legal principle that when there are two
exemptions available for the same product-one prescribing a lower concessional rate and the other a higher one-
the benefit of lower rate should prevail. At any rate, after examination of the issue in all its aspects, Board has
felt that exemption to Human Chorionic Gonadotrophin as Life Saving Drugs should not be denied if the same
has been certified as applicable for human use by the Drug Controller / Assistant Drug Controller. However, if
the same is used in animals i.e. for veterinary use, the concessional duty of 15% will be applicable as per entry
No.14 of lost 1 annexed to the said notification.
4. Pending cosignments , if any, lying at the ports/ICDs etc. may be cleared on the basis of the above
instructions. In case there is any difficulty in implementing the aforesaid instruction, the same may please be
brought to the notice of the Board at an early date.
Sd/
(C.P. Goyal)
Sr. Technical Officer (TU